Abbott Laboratories (ABT) Short-term Investments (2009 - 2026)

Abbott Laboratories' Short-term Investments history runs 18 years deep, the most recent figure standing at $492.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 57.69% year-over-year to $492.0 million; the TTM figure through Mar 2026 stood at $492.0 million (up 57.69% YoY), while the FY2025 annual figure was $417.0 million, up 18.8% from the prior year.
• Short-term Investments came in at $492.0 million for Q1 2026 at Abbott Laboratories, up from $417.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $492.0 million in Q1 2026 to a low of $222.0 million in Q3 2025.
• A 5-year average of $341.4 million and a median of $338.0 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments plunged 36.0% in 2022 and soared 57.69% in 2026, its largest moves.
• Abbott Laboratories' Short-term Investments stood at $288.0 million in 2022, then jumped by 32.99% to $383.0 million in 2023, then decreased by 8.36% to $351.0 million in 2024, then rose by 18.8% to $417.0 million in 2025, then grew by 17.99% to $492.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $492.0 million, $417.0 million, and $222.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison